Lee Danner & Bass Inc Bristol Myers Squibb CO Transaction History

Lee Danner & Bass Inc

$1.17 Billion
Q4 2023

A detailed history of Lee Danner & Bass Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lee Danner & Bass Inc holds 45,853 shares of BMY stock, worth $1.82 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

45,853

Previous 70,474 34.94%

Holding current value

$1.82 Million

Previous $4.09 Million 42.47%

% of portfolio

0.2%

Previous 0.37%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$48.48 - $57.85 $1.19 Million - $1.42 Million	-24,621 Reduced 34.94%	45,853 $2.35 Million
Q3 2023 Oct 27, 2023	SELL	$57.89 - $64.73 $130,599 - $146,030	-2,256 Reduced 3.1%	70,474 $4.09 Million
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $147,807 - $164,116	-2,320 Reduced 3.09%	72,730 $4.65 Million
Q1 2023 May 02, 2023	SELL	$65.71 - $74.53 $12,484 - $14,160	-190 Reduced 0.25%	75,050 $5.2 Million
Q4 2022 Feb 01, 2023	SELL	$68.48 - $81.09 $15,476 - $18,326	-226 Reduced 0.3%	75,240 $5.41 Million

Q3 2022 Oct 31, 2022	SELL	$0.13 - $76.84 $67 - $39,726	-517 Reduced 0.68%	75,466 $5.37 Million
Q2 2022 Jul 25, 2022	SELL	$72.62 - $79.98 $82,423 - $90,777	-1,135 Reduced 1.47%	75,983 $5.85 Million
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $108,512 - $130,115	-1,765 Reduced 2.24%	77,118 $5.63 Million
Q4 2021 Jan 27, 2022	SELL	$53.63 - $62.52 $433,062 - $504,849	-8,075 Reduced 9.29%	78,883 $4.92 Million
Q3 2021 Nov 01, 2021	BUY	$59.17 - $69.31 $249,283 - $292,003	4,213 Added 5.09%	86,958 $5.15 Million
Q2 2021 Jul 27, 2021	SELL	$61.91 - $67.42 $91,131 - $99,242	-1,472 Reduced 1.75%	82,745 $5.53 Million
Q1 2021 Apr 29, 2021	BUY	$59.34 - $66.74 $22,430 - $25,227	378 Added 0.45%	84,217 $5.32 Million
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $78,468 - $88,919	-1,359 Reduced 1.6%	83,839 $5.2 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $294,041 - $325,836	-5,120 Reduced 5.67%	85,198 $5.14 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $1.36 Million - $1.59 Million	24,849 Added 37.96%	90,318 $5.31 Million
Q1 2020 May 04, 2020	BUY	$46.4 - $67.43 $166,808 - $242,410	3,595 Added 5.81%	65,469 $3.65 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $843,262 - $1.1 Million	17,136 Added 38.3%	61,874 $3.97 Million
Q3 2019 Oct 30, 2019	BUY	$42.77 - $50.71 $4,277 - $5,071	100 Added 0.22%	44,738 $2.27 Million
Q1 2019 May 06, 2019	SELL	$45.12 - $53.8 $7,896 - $9,415	-175 Reduced 0.39%	44,638 $2.13 Million
Q4 2018 Jan 29, 2019	SELL	$48.76 - $63.23 $19,650 - $25,481	-403 Reduced 0.89%	44,813 $2.33 Million
Q3 2018 Nov 06, 2018	SELL	$55.19 - $62.25 $6,898 - $7,781	-125 Reduced 0.28%	45,216 $2.81 Million
Q1 2018 May 02, 2018	BUY	$59.92 - $68.98 $179 - $206	3 Added 0.01%	45,341 $2.87 Million
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $117,842 - $128,478	-1,966 Reduced 4.16%	45,338 $2.78 Million
Q3 2017 Oct 27, 2017	BUY	$55.23 - $63.74 $2.61 Million - $3.02 Million	47,304	47,304 $3.02 Million

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lee Danner & Bass Inc with notifications on news.

Account

Lee Danner & Bass Inc Bristol Myers Squibb CO Transaction History